Endothelial dysfunction and pathophysiological correlates in atrial fibrillation

Heart

Volumn 95, Issue 2, 2009, Pages 102-106

  Guazzi, M ^a   Arena, R ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD RHEOLOGY; CARDIOPULMONARY FUNCTION; DYSPNEA; ENDOTHELIAL DYSFUNCTION; FATIGUE; FUNCTIONAL STATUS; HEART ATRIUM FIBRILLATION; HUMAN; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

ATRIAL FIBRILLATION; C-REACTIVE PROTEIN; CARBON DIOXIDE; ENDOTHELIUM, VASCULAR; HUMANS; MECHANORECEPTORS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RENIN-ANGIOTENSIN SYSTEM;

EID: 61449176167     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2007.135277     Document Type: Review

References (50)

1. Vane JR, Anggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med 1990;323:27-36.
2. Celermajer DS, Sorensen KE, Spiegelhalter DJ, et al. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol 1994;24:471-6.
3. McVeigh GE, Brennan GM, Johnston GD, et al. Impaired endothelium-dependent and -independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1992;35:771-6.
4. Paniagua OA, Bryant MB, Panza JA. Role of endothelial nitric oxide in shear stress-induced vasodilation in human microvasculature. Diminished activity in hypertensive and hypercholesterolemic patients. Circulation 2001;103:1752-8.
5. Suh HS, Park YW, Kang JH, et al. Vascular endothelial dysfunction tested by blunted response to endothelium-dependent vasodilation by salbutamol and its related factors in uncomplicated pre-menopausal obese women. Int J Obes (Lond) 2005;29:217-22.
6. Chowienczyk PJ, Watts GF, Cockeroft JR, et al. Impaired endothelium dependent vasodilatation of forearm resistance vessels in hypercholesterolaemia. Lancet 1992;340:1430-2.
7. Celermajer DS, Sorensen KE, Georgakopoulos D, et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 1993;88:2149-55.
8. Barac A, Campia U, Panza JA. Methods for evaluating endothelial function in humans. Hypertension 2007;49:748-60.
9. Katz SD, Hryniewicz K, Hriljac I, et al. Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure. Circulation 2005;111:310-1.
10. Hijmering ML, Stroes ESG, Olijhoek Hutten BAJ, et al. Sympathetic activation markedly reduces endothelium-dependent flow-mediated vasodilation. J Am Coll Cardiol 2002;39:683-8.
11. 2 during low- and high-intensity contractions. J Appl Physiol 2002;92:461- 8.
12. Deanfield JE, Halcox JP, Rabelik TJ. Endothelial function and dysfunction. Testing and clinical relevance. Circulation 2007;115:1285-95.
13. Minamino T, Kitakaze M, Sato H, et al. Plasma levels of nitrite/nitrate and platelet cGMP levels are decreased in patients with atrial fibrillation. Arterioscler Thromb Vasc Biol 1997;17:3191-5.
14. Takahashi N, Ishibashi Y, Shimade T, et al. Atrial fibrillation impairs endothelial function of forearm vessels in humans. J Cardiac Fail 2001;7:45-54.
15. Takahashi N, Ishibashi Y, Shimade T, et al. Impaired exercise-induced vasodilatation in chronic atrial fibrillation. Role of endothelium derived nitric oxide. Circ J 2002;66:583-8.
16. Donald AE, Charakida M, Cole TJ, et al. Non-invasive assessment of endothelial function. Which technique? J Am Coll Cardiol 2006;48:1846-50.
17. Skalidis EI, Zacharis EA, Tsetis DK, et al. Endothelial cell function during atrial fibrillation and after restoration of sinus rhythm. Am J Cardiol 2007;99:1258-62.
18. Guazzi M, Berti M, Belletti S, et al. Exercise metaboreflex activation and endothelial function impairment in atrial fibrillation. Am J Physiol Heart Circ Physiol 2006;291:H2396-402.
19. Guazzi M, Belletti S, Lenatti L, et al. Effects of cardioversion of atrial fibrillation on endothelial function in hypertension and diabetes. Eur J Clin Invest 2007;37:26-34.
20. European Heart Rhythm Association; Heart Rhythm Society, Fuster V, Ryden LE, Cannom DS, et al; American College of Cardiology; American Heart Association Task Force on Practice Guidelines; European Society of Cardiology Committee for Practice Guidelines; Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol 2006;48:854-906.
21. Scott AC, Francis DP, Davies LC, et al. Contribution of skeletal muscle "ergoreceptors" in the human leg to respiratory control in chronic heart failure. J Physiol 2000;529:863-70.
22. Smith SA, Mammen PPA, Mitchell JH, et al. Role of the exercise pressor reflex in rats with dilated cardiomyopathy. Circulation 2003;108:1126-32.
23. Guazzi M, Belletti S, Tumminello G, et al. Exercise hyperventilation, dyspnea sensation, and ergoreflex activation in lone atrial fibrillation. Am J Physiol Heart Circ Physiol 2004;287:H2899-905.
24. Carnes CA, Chung MK, Nakayama T, et al. Ascorbate attenuates atrial pacing- induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation. Circ Res 2001;89:e32-8.
25. Ülker S, McKeown PP, Bayraktutan U. Vitamins reverse endothelial dysfunction through regulation of eNOS and NAD(P)H oxidase activities. Hypertension 2003;41:534-9.
26. Cai H, Li Zongming, Goette A, et al. Downregulation of endocardial nitric oxide sinthase expression and nitric oxide production in atrial fibrillation. Potential mechanisms for atrial thrombosis and stroke. Circulation 2002;106:2854-8.
27. Vallance P, Chan N. Endothelial function and nitric oxide: clinical relevance. Heart 2001;85:342-50.
28. Helmlinger G, Berk BC, Nerem RM. Pulsatile and steady flow-induced calcium oscillations in single cultured endothelial cells. J Vasc Res 1996;33:360-9.
29. James NL, Harrison DG, Nerem RM. Effects of shear on endothelial cell calcium in the presence and absence of ATP. FASEB J 1995;9:968-73.
30. Govers R, Rabelink TJ. Cellular regulation of endothelial nitric oxide synthase. Am J Physiol Renal Physiol 2001;280:F193-206.
31. Sun D, Huang A, Smith CJ, et al. Enhanced release of prostaglandins contributes to flow-induced arteriolar dilation in eNOS knockout mice. Circ Res 1999;85:288-93.
32. Bruins P, Velthuis H, Yazdanbakhsh AP, et al. Activation of the complement system during and after cardiopulmonary bypass surgery. Postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation 1997;96:3542-8.
33. Chung MK, Martin OD, Sprecher D, et al. C-reactive protein elevation in patients with atrial arrhythmias. Inflammatory mechanisms and persistence of atrial fibrillation. Circulation 2001;104:2886-91.
34. Dudley SC, Hoch NE, McCann LA, et al. Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage. Role of the NADPH and xantine oxidases. Circulation 2005;112: 1266-1273.
35. Kallergis EM, Manios EG, Kanaoupakis EM, et al. The role of the post-cardioversion time course of hs-CRP levels in clarifying the relationship between inflammation and persistence of atrial fibrillation. Heart 2008;94:200-4.
36. Pasceri V, Willerson JT, Yeh ETH. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000;102:2165-8.
37. Wachtell K, Lehto M, Gerdts E, et al. Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol. The losartan intervention for end point reduction in hypertension (LIFE) study. J Am Coll Cardiol 2005;45:712-9.
38. Bourassa MG; Angiotensin II inhibition and prevention of atrial fibrillation and stroke. J Am Coll Cardiol 2005;45:720-1.
39. Boos CJ, Anderson RA, Lip GYH. Is atrial fibrillation an inflammatory disorder? Eur Heart J 2006;27:136-19.
40. Cardin S, Li D, Thorin-Trescases N, et al. Evolution of the atrial fibrillation substrate in experimental congestive heart failure: angiotensin - dependent and - independent pathways. Cardiovasc Res 2003;60:315-25.
41. Kim YM, Guzik TJ, Zhang YH, et al. A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation. Circ Res 2005;97:629-36.
42. Li JM, Shah AM. Mechanism of endothelial cell NADPH oxidase activation by angiotensin II. Role of the p47phox submit. J Biol Chem 2003;278:12094-100.
43. Ehrlich JR, Hohnloser SH, Nattel S. Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence. Eur Heart J 2006;27:512-8.
44. Pardaens K, Van Cleemput J, Vanhaecke J, et al. Atrial fibrillation is associated with a lower exercise capacity in male chronic heart failure patients. Heart 1997;78:564-5.
45. Kuvin JT, Patel AR, Sliney KA, et al. Peripheral vascular endothelial function testing as a noninvasive indicator of coronary artery disease. J Am Coll Cardiol 2001;38:1843-9.
46. Singh SN, Tang C, Singh BN, et al, for the SAFE-T Investigators. Quality of life and exercise performance in patients in sinus rhythm versus persistent atrial fibrillation. A Veterans Affairs cooperative studies program substudy. J Am Coll Cardiol 2006;48:721-730.
47. Chung MK, Shemanski L, Sherman DG, et al, for the AFFIRM investigators. Functional status in rate- versus rhythm-control strategies for atrial fibrillation. J Am Coll Cardiol 2005;46:1891-9.
48. Guazzi M, Belletti S, Bianco E, et al. Endothelial dysfunction and exercise performance in lone atrial fibrillation or associated with hypertension or diabetes. Different results with cardiversion. Am J Physiol Heart Circ Physiol 2006;291:H921-8.
49. Jahangir A, Lee V, Friedman PA, et al. Long-term progression and outcomes with aging in patients with lone atrial fibrillation. A 30-year follow-up study. Circulation 2007;115:3050-6.
50. Lewis GD, Lachmann J, Camuso J, et al. Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure. Circulation 2007;115:59-66.